Ovarian tumors express elevated levels of mRNAs encoding each of the
subunits of TFIIIC2. cDNAs were generated by reverse transcription of
RNA from normal ovarian tissue (N, odd lanes) or ovarian tumors (T,
even lanes) from patients 1–4, as indicated. These cDNAs were PCR
amplified by using primers specific for TFIIIC220, TFIIIC110,
TFIIIC102, TFIIIC90, TFIIIC63, and GAPDH, as indicated.